Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication

NCT ID: NCT04741906

Last Updated: 2024-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

225 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-08-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim of the study is to examine the feasibility of dental implant insertion in patients receiving high, adjuvant and low dose \> 4 years.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The hypothesis of the present study is that dental implant therapy using submerged healing is feasible and predictable in patients receiving high, adjuvant or low dose AR for more than 4 years, as documented by clinical and radiographic signs of osseointegration after 3-4 months, sufficient implant stability for abutment connection, and implant survival rates comparable to those of healthy individuals after one year of prosthetic loading.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Missing Teeth Implants Cancer Osteoporosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient with osteoporosis - antiresorptive treatment > 4 years. Previous tooth extraction

Patient with osteoporosis - antiresorptive treatment \> 4 years who have had previous tooth extraction without development of MRONJ

Dental implant surgery

Intervention Type PROCEDURE

Dental surgery in patients treated with antiresorptive medication

Prosthetic treatment

Intervention Type PROCEDURE

Prosthetic treatment and loading of the dental implants

Patient with osteoporosis - antiresorptive treatment > 4 years. Previous resection

Patient with osteoporosis - antiresorptive treatment \> 4 years who have lost teeth due to having previous osteonecrosis of the jaw which has been successfully surgically treated and healed for at least 3 months without recurrence

Dental implant surgery

Intervention Type PROCEDURE

Dental surgery in patients treated with antiresorptive medication

Prosthetic treatment

Intervention Type PROCEDURE

Prosthetic treatment and loading of the dental implants

Patient with osteoporosis - antiresorptive treatment > 4 years. Simultaneously with resection

Patient with osteoporosis - antiresorptive treatment \> 4 years with ongoing osteonecrosis of the jaw to be surgically treated with block resection of the lower jaw and insertion of a titanium reconstruction plate. Simultaneous insertion of dental implants, or resection of the upper jaw where there is sufficient remaining bone volume to have implants inserted simultaneously (without bone augmentation)

Dental implant surgery

Intervention Type PROCEDURE

Dental surgery in patients treated with antiresorptive medication

Prosthetic treatment

Intervention Type PROCEDURE

Prosthetic treatment and loading of the dental implants

Patient with cancer - adjuvant dose antiresorptive treatment. Previous tooth extraction

Patient with cancer (breast, prostate or multiple myeloma) - adjuvant dose antiresorptive treatment who have had previous tooth extraction without development of MRONJ

Dental implant surgery

Intervention Type PROCEDURE

Dental surgery in patients treated with antiresorptive medication

Prosthetic treatment

Intervention Type PROCEDURE

Prosthetic treatment and loading of the dental implants

Patient with cancer - adjuvant dose antiresorptive treatment. Previous resection

Patient with cancer (breast, prostate or multiple myeloma) - adjuvant dose antiresorptive treatment who have lost teeth due to having previous osteonecrosis of the jaw which has been successfully surgically treated and healed for at least 3 months without recurrence

Dental implant surgery

Intervention Type PROCEDURE

Dental surgery in patients treated with antiresorptive medication

Prosthetic treatment

Intervention Type PROCEDURE

Prosthetic treatment and loading of the dental implants

Patient with cancer - adjuvant dose antiresorptive treatment. Simultaneously with resection

Patient with cancer (breast, prostate or multiple myeloma) - adjuvant dose antiresorptive treatment with ongoing osteonecrosis of the jaw to be surgically treated with block resection of the lower jaw and insertion of a titanium reconstruction plate. Simultaneous insertion of dental implants, or resection of the upper jaw where there is sufficient remaining bone volume to have implants inserted simultaneously (without bone augmentation)

Dental implant surgery

Intervention Type PROCEDURE

Dental surgery in patients treated with antiresorptive medication

Prosthetic treatment

Intervention Type PROCEDURE

Prosthetic treatment and loading of the dental implants

Cancer patient treated with high dose antiresorptive treatment. Previous tooth extraction

Cancer patient treated with high dose antiresorptive treatment who have had previous tooth extraction without development of MRONJ

Dental implant surgery

Intervention Type PROCEDURE

Dental surgery in patients treated with antiresorptive medication

Prosthetic treatment

Intervention Type PROCEDURE

Prosthetic treatment and loading of the dental implants

Cancer patient treated with high dose antiresorptive treatment. Previous resection

Cancer patient treated with high dose antiresorptive treatment who have lost teeth due to having previous osteonecrosis of the jaw which has been successfully surgically treated and healed for at least 3 months without recurrence

Dental implant surgery

Intervention Type PROCEDURE

Dental surgery in patients treated with antiresorptive medication

Prosthetic treatment

Intervention Type PROCEDURE

Prosthetic treatment and loading of the dental implants

Cancer patient treated with high dose antiresorptive treatment. Simultaneously with resection

Cancer patients (breast, prostate or multiple myeloma) treated with high dose antiresorptive treatment with ongoing osteonecrosis of the jaw to be surgically treated with block resection of the lower jaw and insertion of a titanium reconstruction plate. Simultaneous insertion of dental implants, or resection of the upper jaw where there is sufficient remaining bone volume to have implants inserted simultaneously (without bone augmentation)

Dental implant surgery

Intervention Type PROCEDURE

Dental surgery in patients treated with antiresorptive medication

Prosthetic treatment

Intervention Type PROCEDURE

Prosthetic treatment and loading of the dental implants

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dental implant surgery

Dental surgery in patients treated with antiresorptive medication

Intervention Type PROCEDURE

Prosthetic treatment

Prosthetic treatment and loading of the dental implants

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient with cancer or osteoporosis, treated with antiresorptive treatment.
* The patients should have sufficient compliance, this includes willingness to have the planned assessments
* The patient should have an expected life span at enrollment of at least 2 years.
* The local bone quality and quantity should be sufficient for implant insertion without bone augmentation and is classified according to the classification by Cawood \& Howell 1988.

Exclusion Criteria

* \> 10 cigarettes daily
* HbA1c \> 53 mmol/mol
* Poor oral hygiene
* Poor general condition: ECOG score 3 or 4.
* Poor prognosis: Expected survival \<2 year is an exclusion cause.
* Presence of metastases of the liver brain.
* Poor local jaw bone quality acc. to Cawood classification stage 3 or 4.
* Unwillingness to comply with the planned assessments and recordings
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Amgen

INDUSTRY

Sponsor Role collaborator

Institut Straumann AG

INDUSTRY

Sponsor Role collaborator

Copenhagen University Hospital at Herlev

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sanne Werner Moeller Andersen

Oral and Maxillofacial Surgeon

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sanne Werner Moeller Andersen, DDS

Role: PRINCIPAL_INVESTIGATOR

Copenhagen University Hospital, Maxillofacial surgery

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Copenhagen University Hospital, Maxillofacial Department

Copenhagen, Danmark, Denmark

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sanne Werner Moeller Andersen, DDS

Role: CONTACT

60625950 ext. 0045

Thomas Kofod, PhD

Role: CONTACT

35450626 ext. 0045

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sanne Werner Moeller Andersen, DDS

Role: primary

60625950 ext. 0045

Thomas Steengaard Kofod, PhD

Role: backup

35450626 ext. 0045

References

Explore related publications, articles, or registry entries linked to this study.

Ottesen C, Andersen SWM, Jensen SS, Kofod T, Gotfredsen K. Medication-related osteonecrosis of the jaw and successful implant treatment in a patient on high-dose antiresorptive medication: A case report. Clin Exp Dent Res. 2022 Oct;8(5):1059-1067. doi: 10.1002/cre2.620. Epub 2022 Jul 27.

Reference Type DERIVED
PMID: 35894761 (View on PubMed)

Andersen SWM, Ottesen C, Gotfredsen K, Jensen SS, Kofod T, Schiodt M. Outcome of healing after dental implant placement in patients with cancer on high-dose antiresorptive medications: a prospective feasibility study. Oral Maxillofac Surg. 2023 Mar;27(1):89-100. doi: 10.1007/s10006-022-01042-5. Epub 2022 Jan 27.

Reference Type DERIVED
PMID: 35084584 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Oral rehabilitation of MRONJ

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.